MedTrace Logo

Dual Task Gait Performance in Pediatric Oncology Patients

NCT04784026 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 40

Last updated 2021-03-05

No results posted yet for this study

Summary

Cancer incidence, which is recognized as the leading cause of death in children worldwide, is gradually increasing.

Most studies on children who survive cancer show that the disease and its treatment have side effects and long-term late effects on the musculoskeletal system, physical function, gait and cognitive skills.

Therefore, dual task gait performance, in which cognitive and motor tasks are performed simultaneously, may be affected in pediatric oncology patients. The aim of this study is to compare gait performance in single and dual task conditions in pediatric oncology patients with healthy controls.

Conditions

  • Pediatric Cancer

Interventions

OTHER

Gait assessment (single)

The single walk will be evaluated with a 10-meter walking test and a G-Walk portable device.

OTHER

Dual task gait assessment (motor+motor)

The dual task gait, 10-meter walking test and a motor (carrying a full water glass) will be combined with the task and evaluated with the G-Walk portable device.

OTHER

Dual tak gait assessment (motor+cognitive)

The dual task gait will be combined with a 10-meter walking test and a cognitive (1-back test) task and evaluated with the G-Walk portable device.

Sponsors & Collaborators

  • Afyonkarahisar Health Sciences University

    lead OTHER

Principal Investigators

  • EMEL TAŞVURAN HORATA, PhD · Afyonkarahisar Health Science University

Eligibility

Min Age
6 Years
Max Age
18 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2021-03-01
Primary Completion
2023-03-20
Completion
2023-03-20

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04784026 on ClinicalTrials.gov